From a cellular laboratory viewpoint, Relafen 750 (Naproxen ) presents a unique case. Its mechanism of effect primarily involves inhibiting cyclooxygenase catalysts , specifically COX-1 and COX-2, thereby reducing website prostaglandin generation. This results in decreased swelling and temperature . The compound's relatively long duration and speci